基于症状的聚类分析对干燥病亚型进行分类:一项强调疾病严重程度与治疗不一致的国际队列研究
研究利用干燥病国际协作临床联盟(SICCA)登记库和干燥病基金会调查数据,按干燥、疲劳、疼痛水平进行层次聚类,在1454例SICCA登记者和2920例调查参与者中均识别出4个相似的聚类;高症状负担聚类总症状更多、生活质量更低但疾病严重程度更低,却最常接受免疫调节治疗。
要点
- 在SICCA登记者和干燥病基金会调查参与者中均识别出4个相似的症状聚类:低症状负担(LSB)、干燥伴低疼痛低疲劳(DLP)、干燥伴高疼痛低至中度疲劳(DHP)、高症状负担(HSB)。
- HSB聚类个体总症状更多、生活质量更低,但疾病严重程度低于其他聚类。
- 尽管实验室检查和器官受累显示病情较轻,HSB聚类个体接受免疫调节治疗最频繁。
核心结论
- 识别出4个基于症状的干燥病聚类,症状负担与免疫调节药物使用和干燥病终末器官或实验室异常不相关。
- 研究结果突显客观指标与治疗之间的不一致,并为提出的基于症状的聚类方法提供更新。
研究设计与样本
- 研究使用干燥病国际协作临床联盟(SICCA)登记库和干燥病基金会调查的数据。
- 按干燥、疲劳、疼痛水平进行症状层次聚类。
- 使用国际和美国队列进行多重逻辑回归分析比较聚类,包括症状、生活质量、药物使用和系统表现差异的比较。
- 分析纳入1454例SICCA登记者和2920例干燥病基金会调查参与者。
主要发现
- 在1454例SICCA登记者和2920例干燥病基金会调查参与者中识别出4个相似聚类:低症状负担(LSB)、干燥伴低疼痛低疲劳(DLP)、干燥伴高疼痛低至中度疲劳(DHP)、高症状负担(HSB)。
- SICCA登记者中各聚类症状特征匹配分布为LSB聚类10%、DLP聚类30%、DHP聚类23%、HSB聚类37%。
- 调查参与者中各聚类症状特征匹配分布为LSB聚类23%、DLP聚类14%、DHP聚类21%、HSB聚类42%。
- HSB聚类个体总症状更多、生活质量更低,但疾病严重程度低于其他聚类。
- 尽管实验室检查和器官受累显示病情较轻,HSB聚类个体接受免疫调节治疗最频繁。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although symptom relief is a critical aspect for successful drug development in Sjögren's disease, patient experiences with Sjögren's-related symptoms are understudied. Our objective was to determine how pain, dryness, and fatigue, the cardinal symptoms of Sjögren's disease, drive cluster phenotypes. METHODS: We used data from the Sjögren's International Collaborative Clinical Alliance (SICCA) Registry and a Sjögren's Foundation survey. We performed hierarchical clustering of symptoms by levels of dryness, fatigue, and pain. Using international and US cohorts, we performed multiple logistic regression analysis to compare the clusters, which included comparisons of differences in symptoms, quality of life (QoL), medication use, and systemic manifestations. RESULTS: Four similar clusters were identified among 1,454 SICCA registrants and 2,920 Sjögren's Foundation survey participants: 1) low symptom burden in all categories (LSB); 2) dry with low pain and low fatigue (DLP); 3) dry with high pain and low to moderate fatigue (DHP); and 4) high symptom burden in all categories (HSB). Distribution of SICCA registrants matching the symptom profile for each cluster was 10% in the LSB cluster, 30% in the DLP cluster, 23% in the DHP cluster, and 37% in the HSB cluster. Distribution of survey participants matching the symptom profile for each cluster was 23% in the LSB cluster, 14% in the DLP cluster, 21% in the DHP cluster, and 42% in the HSB cluster. Individuals in the HSB cluster had more total symptoms and lower QoL but lower disease severity than those in the other clusters. Despite having milder disease as measured by laboratory tests and organ involvement, individuals in the HSB cluster received immunomodulatory treatment most often. CONCLUSION: We identified 4 symptom-based Sjögren's clusters and showed that symptom burden and immunomodulatory medication use do not correlate with Sjögren's end-organ or laboratory abnormalities. Findings highlight a discordance between objective measures and treatments and offer updates to proposed symptom-based clustering approaches.
引用
- McCoy SS, Woodham M, Bartels CM, et al. Symptom-Based Cluster Analysis Categorizes Sjögren's Disease Subtypes: An International Cohort Study Highlighting Disease Severity and Treatment Discordance. Arthritis Rheumatol. 2022. PMID: 35594474. doi:10.1002/art.42238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。